Glutamate, Miscellaneous – SGLT2 Inhibitor targeting orphan nuclear receptor

In agreement with studies on additional bNAbs, PGDM1400 monotherapy did not fully suppress chronic HIV\1 infection for a prolonged period, however considering that PGDM1400 is one of the most potent and broad bNAbs known, it can be an important component in therapeutic combination of different bNAbs

imacst April 15, 2022 Glutamate, Miscellaneous

In agreement with studies on additional bNAbs, PGDM1400 monotherapy did not fully suppress chronic HIV\1 infection for a prolonged period, however considering that PGDM1400 is…

Category: Glutamate, Miscellaneous